A detailed history of Keel Point, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Keel Point, LLC holds 6,617 shares of AZN stock, worth $444,530. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,617
Previous 6,610 0.11%
Holding current value
$444,530
Previous $515,000 -0.0%
% of portfolio
0.04%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $536 - $613
7 Added 0.11%
6,617 $515,000
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $52,312 - $63,289
783 Added 13.44%
6,610 $515,000
Q1 2024

Apr 16, 2024

BUY
$61.03 - $69.57 $47,908 - $54,612
785 Added 15.57%
5,827 $394,000
Q4 2023

Jan 30, 2024

BUY
$61.89 - $69.28 $8,478 - $9,491
137 Added 2.79%
5,042 $339,000
Q3 2023

Oct 26, 2023

SELL
$64.85 - $71.7 $61,996 - $68,545
-956 Reduced 16.31%
4,905 $332,000
Q2 2023

Jul 12, 2023

SELL
$69.91 - $75.81 $29,991 - $32,522
-429 Reduced 6.82%
5,861 $419,000
Q1 2023

Apr 03, 2023

SELL
$63.15 - $71.6 $25,702 - $29,141
-407 Reduced 6.08%
6,290 $436,000
Q4 2022

Jan 17, 2023

BUY
$54.21 - $70.44 $33,447 - $43,461
617 Added 10.15%
6,697 $0
Q3 2022

Oct 05, 2022

BUY
$53.02 - $135.75 $3,128 - $8,009
59 Added 0.98%
6,080 $333,000
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $40,711 - $48,873
687 Added 12.88%
6,021 $399,000
Q1 2022

Apr 27, 2022

SELL
$55.72 - $67.12 $15,657 - $18,860
-281 Reduced 5.0%
5,334 $354,000
Q4 2021

Jan 31, 2022

BUY
$54.02 - $63.83 $8,211 - $9,702
152 Added 2.78%
5,615 $327,000
Q3 2021

Nov 04, 2021

BUY
$55.56 - $60.79 $303,524 - $332,095
5,463 New
5,463 $328,000
Q2 2021

Aug 06, 2021

SELL
$48.42 - $60.18 $225,830 - $280,679
-4,664 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$48.42 - $60.18 $50,889 - $63,249
-1,051 Reduced 18.39%
4,664 $279,000
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $269,519 - $311,124
5,715 New
5,715 $284,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Keel Point, LLC Portfolio

Follow Keel Point, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.